Biological pathways underlying the relationship between childhood maltreatment and Multimorbidity: A two-step, multivariable Mendelian randomisation study

EarlyCause consortium

Research output: Contribution to journalArticlepeer-review

1 Citation (SciVal)

Abstract

Childhood maltreatment has been associated with multimorbidity of depression, coronary artery disease and type 2 diabetes. However, the biological mechanisms underlying this association remain unclear. We employed two-step and multivariable Mendelian randomisation (MR) to understand the role of three potential biological mediating mechanisms – inflammation (92 proteins), metabolic processes (54 markers), and cortisol – in the link between childhood maltreatment liability and multimorbidity. Using summary statistics from large-scale genome-wide association studies of European ancestry for childhood maltreatment (N = 185,414) and multimorbidity (Neffective = 156,717), we tested for the presence of an indirect effect via each mediator individually. We found a potential role of metabolic pathways. Up to 11% of the effect of childhood maltreatment on multimorbidity was mediated by triglycerides (indirect effect [95% CI]: 0.018 [0.009–0.027]), 8% by glycated haemoglobin (indirect effect: 0.013 [0.003–0.023]), and up to 7% by high-density lipoprotein cholesterol (indirect effect: 0.011 [0.005–0.017]). We did not find evidence for mediation via any inflammatory protein or cortisol. Our findings shed light on the biological mechanisms linking childhood maltreatment liability to multimorbidity, highlighting the role of metabolic pathways. Future studies may explore underlying pathways via non-biological mediators (e.g., lifestyle factors) or via multiple mediators simultaneously.

Original languageEnglish
Pages (from-to)59-69
Number of pages11
JournalBrain Behavior and Immunity
Volume126
Early online date1 Feb 2025
DOIs
Publication statusPublished - 31 May 2025

Bibliographical note

Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.

Data Availability Statement

Analysis code for this study has been made publicly available on GitHub and can be accessed at https://github.com/VilteBaltra/MR-biological-pathways. GWAS data sources are listed in Table S1.

Funding

This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 848,158 (EarlyCause) and from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement No 101137146. UK participants in Horizon Europe Project STAGE are supported by UKRI grant numbers 10,112,787 (Beta Technology), 10,099,041 (University of Bristol), and 10,109,957 (Imperial College London). EW and VB are also funded from UK Research and Innovation (UKRI) under the UK government’s Horizon Europe / ERC Frontier Research Guarantee [BrainHealth, grant number EP/Y015037/1]. The work of CAMC is supported by the European Union's HorizonEurope Research and Innovation Programme (FAMILY, grant agreement No 101057529; HappyMums, grant agreement No 101057390) and the European Research Council (TEMPO; grant agreement No 101039672). The funders had no role in study design; the collection, analysis and interpretation of data; the writing of the report; and in the decision to submit the article for publication. This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No 848,158 (EarlyCause) and from the European Union's Horizon Europe Research and Innovation Programme under grant agreement No 101137146. UK participants in Horizon Europe Project STAGE are supported by UKRI grant numbers 10,112,787 (Beta Technology), 10,099,041 (University of Bristol), and 10,109,957 (Imperial College London). EW and VB are also funded from UK Research and Innovation (UKRI) under the UK government's Horizon Europe / ERC Frontier Research Guarantee [BrainHealth, grant number EP/Y015037/1]. The work of CAMC is supported by the European Union's HorizonEurope Research and Innovation Programme (FAMILY, grant agreement No 101057529; HappyMums, grant agreement No 101057390) and the European Research Council (TEMPO; grant agreement No 101039672). The funders had no role in study design; the collection, analysis and interpretation of data; the writing of the report; and in the decision to submit the article for publication. Analysis code for this study has been made publicly available on GitHub and can be accessed at https://github.com/VilteBaltra/MR-biological-pathways.

FundersFunder number
Imperial College London
HORIZON EUROPE Framework Programme
European Union's Horizon Europe Research and Innovation Programme
CAMC
European Union's HorizonEurope Research and Innovation Programme
Horizon 2020
UK Research and Innovation
Horizon 2020 Framework Programme848,158
TEMPO101039672
European Research CouncilEP/Y015037/1
University of Bristol10,109,957
FAMILY101057390, 101057529
European Union’s Horizon Europe research and innovation programme10,112,787, 101137146

Keywords

  • Childhood maltreatment
  • Coronary artery disease
  • Depression
  • Mendelian randomisation
  • Multimorbidity
  • Type 2 diabetes

ASJC Scopus subject areas

  • Immunology
  • Endocrine and Autonomic Systems
  • Behavioral Neuroscience

Fingerprint

Dive into the research topics of 'Biological pathways underlying the relationship between childhood maltreatment and Multimorbidity: A two-step, multivariable Mendelian randomisation study'. Together they form a unique fingerprint.

Cite this